Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Suzuken Co ( (JP:9987) ).
Suzuken Co., Ltd. announced the results of its share repurchase for May 2025, acquiring 332,000 common shares for approximately ¥1.72 billion through market purchases on the Tokyo Stock Exchange. This repurchase is part of a larger plan to buy back up to 5.2 million shares by March 2026, reflecting the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (JP:9987) stock is a Hold with a Yen5730.00 price target. To see the full list of analyst forecasts on Suzuken Co stock, see the JP:9987 Stock Forecast page.
More about Suzuken Co
Suzuken Co., Ltd. operates in the pharmaceutical industry, primarily focusing on the distribution of pharmaceuticals and medical devices. It is listed on the Tokyo, Nagoya, and Sapporo Stock Exchanges.
YTD Price Performance: 13.28%
Average Trading Volume: 242,863
Technical Sentiment Signal: Buy
Current Market Cap: Yen301.6B
See more insights into 9987 stock on TipRanks’ Stock Analysis page.